Literature DB >> 22513318

Endoscopic management of gastroesophageal reflux disease: a review.

Chaitan K Narsule1, Jon O Wee, Hiran C Fernando.   

Abstract

Gastroesophageal reflux disease is the most common esophageal disorder encountered in the United States. Gastroesophageal reflux disease symptoms are associated with a negative quality of life and increased healthcare costs and therefore require an effective management strategy. Although proton pump inhibitors remain the primary treatment of gastroesophageal reflux disease, they do not cure the disorder and can leave patients with persistent symptoms despite treatment. Moreover, patients are still at risk of developing such complications as peptic strictures, Barrett's metaplasia, and esophageal cancer. Although laparoscopic Nissen fundoplication has been the conventional alternative treatment for those patients who develop complications of gastroesophageal reflux disease, have intractable symptoms, or wish to discontinue taking proton pump inhibitors, investigators have persisted in developing a number of endoscopic approaches to the treatment of gastroesophageal reflux disease. The present report reviews the history of endoscopic treatments devised for the management of gastroesophageal reflux disease and explores the published data and outcomes associated with the latest approach-endoscopic fundoplication using the EsophyX2 device.
Copyright © 2012. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22513318     DOI: 10.1016/j.jtcvs.2012.03.025

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  2 in total

1.  Ear, nose and throat (ENT) manifestations and complications of reflux.

Authors:  Sabrina Brar; Carolina Watters; Natalie Watson; Martin Birchall; Yakubu Karagama
Journal:  Frontline Gastroenterol       Date:  2022-06-07

2.  Esophgeal Perforation and Bilateral Empyema Following Endoscopic EsophyX Transoral Incisionless Fundoplication.

Authors:  Hawa Edriss; Amal El-Bakush; Kenneth Nugent
Journal:  Clin Endosc       Date:  2014-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.